The 12th Human Amyloid Imaging will take place in Miami, Florida on January 17-19, 2018. My co-organizers for the meeting will be, once more, Bill Klunk (University of Pittsburgh), Chet Mathis (University of Pittsburgh) and Bill Jagust (University of California, Berkeley).

At HAI 2018 we will continue to emphasize ample lively discussion of core controversies such as: what does the presence of brain amyloid mean, how should it be measured, how does it change, and what does it portend? Our discussions primarily sprung from brief presentations by active investigators who will report unpublished, cutting-edge research in human imaging of amyloid-beta and/or other biomarkers that pertain to Alzheimer’s-related disease.

To assemble HAI we will accept and peer-review only the most recent, important work, abstract submissions. The 2017 meeting drew more than 365 attendees and showcased 116 posters from research groups spanning North America, Europe, East Asia, and Australia.

Research reports are complemented at HAI by Keynote presentations that are intended to cross disciplines and provide perspective from neuropathology, neurochemistry, psychology, neurology, molecular imaging, clinical trials and biomarker research.

In 2018, we are pleased to welcome two such presentations from Drs. William Seeley (University of California, San Francisco) and Peter Davies (Northwell Health). In addition to these, we will continue our lectures on basic methods in amyloid PET.

Until our 12th edition of HAI, we invite you to bookmark our website, follow us on social media and save the dates in your calendars!